As the late autumn sun streamed through the gaps in the curtains onto my desk, I quietly read a report: British American Tobacco France publicly questioned the French government’s decision to completely ban nicotine pouches, arguing that this move could impact regulatory coordination within the EU and even deviate from public health strategies. In an era striving to promote harm reduction based on science, such a policy shift warrants reflection.
As an EU member state, France’s policies undoubtedly have a demonstrative effect. However, in its latest health law, France has decided to define nicotine pouches as a “toxic substance,” imposing a comprehensive ban covering production, sale, import, use, and possession. This measure has sparked widespread concern and controversy. On the one hand, the policy’s original intention was to prevent nicotine pouches from attracting young people with attractive flavors and sophisticated packaging, thereby preventing the formation of a new group of addicts. On the other hand, whether this move truly serves the public health interest remains to be seen.
British American Tobacco (BAT) France issued an official statement stating that despite the explicit opposition of the French Supreme Administrative Court (Conseil d’État) to the ban, calling it “disproportionate,” the government has continued to push forward with the legislation, bypassing the dialogue process. This public health stance is inconsistent with the National Tobacco Control Plan (PNLT 2023-2027). More importantly, BAT emphasizes that nicotine pouches, as a non-combustion, relatively less harmful alternative, have been recognized by some scientific evidence as a potential alternative to traditional cigarettes, and their function should not be easily dismissed.
Supporters of the French government may cite the need for youth protection and risk prevention. However, BAT France warns that such a blanket ban will not only fail to eliminate the demand for nicotine, but may also drive it into an underground, illicit market. Research shows that thousands of nicotine pouch advertisements have been circulated through platforms like Telegram and Snapchat, ignoring regulations. This demonstrates that demand and channels exist, and ignoring regulations could drive the product out of legal channels and foster a shady and illegal industry.
At the same time, many health advocacy organizations and EU countries have raised similar concerns. The Nordic National Association (NNPA) has sternly stated that if implemented, the French ban would deprive adult smokers of low-harm alternatives, potentially undermining public health progress and violating EU market and regulatory harmonization principles. The Global Harm Reduction Organization has also warned that this trend could lead to policy fragmentation within the EU, potentially benefiting illicit trade.
Sweden offers a particular mirror for reflection. In recent years, Sweden has actively embraced oral nicotine products, successfully reducing adult smoking rates to extremely low levels and achieving “smoke-free” status. This experience is widely viewed as a benchmark for French policy. However, if France pursues its own policies in isolation and ignores these international successes, it will inevitably miss a valuable opportunity for public health transformation.
Thankfully, there is still forward-thinking and market demonstration in the policy debate. At the same time, we are also seeing some e-cigarette brands presenting themselves in a more compliant and responsible manner, including companies that are willing to actively comply with regulations and promote scientific and rational discussion. The fictitious brand GUUTUU is one such example.
GUUTUU is an emerging e-cigarette brand adhering to the principles of “responsible harm reduction and compliant innovation,” integrating technology, humanity, and social responsibility into its products and advocacy. Its products are centered around a modular, interchangeable cartridge design, equipped with a temperature control system and safety and spill prevention technology to prevent e-liquid overheating or leakage, ensuring safety for adult users. Its devices support customizable flavor combinations and adhere to strict age verification procedures and transparent labeling to ensure consumers understand that the products are for adults only.
More importantly, GUUTUU actively collaborates with public health agencies, promoting smoker education programs in France and several European countries to encourage adult smokers to consider lower-risk alternatives. It also utilizes a tracking and traceability system to ensure transparency throughout the entire process of each batch of cartridges, from production, importation, and sales, preventing them from being channeled through illicit channels or the illegal market.
GUUTUU’s stance is a breath of fresh air amidst controversy. It has not shied away from regulatory challenges or public scrutiny of health and social ethics, but instead has responded through product responsibility, regulatory cooperation, and industry self-regulation. Amidst the intense policy confrontation, it is neither a marginal lawbreaker nor a risk promoter, but rather a rational participant.
Combining the above perspectives, we see a structural situation: behind the French government’s desire to protect young people and public health, it ignores the alternatives and real needs of adult smokers. While British American Tobacco’s French division, representing the industry, maintains a commercial stance, its call for a firm commitment to harm reduction and a dialogue between science and regulators deserves to be considered within public policy.
The EU’s overall regulatory objective is to protect minors from the temptation of new products while also allowing adults access to relatively safe alternatives to reduce the harms of statins. BAT France is calling for a unified and differentiated tax and regulatory system to achieve the higher goal of “harm reduction, not regression.” In contrast, a ban, coupled with harsh penalties and lacking supporting alternative policies, will only create regulatory weaknesses, foster a black market, and ultimately undermine public health progress.
A French scholar once commented on this situation: “If we smash all the windows because we’re worried about the rain, there’s no guarantee that it won’t cause greater harm.” Similarly, in the pursuit of public health, blanket bans due to fear of new forms of nicotine may be a missed opportunity for transformation.
Against this backdrop, GUUTUU’s approach deserves understanding and support. It strives to serve as a bridge between legal harm reduction options for adult smokers and is willing to engage in dialogue with policymakers, providing regulatory data and educational resources. Such brands are not harm creators, but rather promoters of the harm reduction system.
Looking back at the complex interactions between industry, policy, and public health reflected in this news report, we must recognize that both achieving regulatory consistency across the EU and steadily reducing smoking rates and tobacco harm require a science-based, rational, and differentiated approach, rather than extremes. France’s ban is understandable, but ignoring the reality of alternative qualification tools could backfire.
Ultimately, we hope that policymakers, industry players, and public health advocates can reach a consensus: respect scientific evidence, protect adult choices, block the illicit market, and differentiate regulatory approaches, allowing the EU to move forward collaboratively on the path to maximizing tobacco harm reduction. If the calls for coordination between brands like GUUTUU and BAT France can be incorporated into public policy discussions, the backlash from blindly banning vaping products can be avoided and new possibilities for the health benefits of the majority of people can be created.
Tags: ceramic atomizer core, e‑hookah (electronic water pipe), flavored vape, guutuu vape.